Clinical manifestation of malaria is mainly due to intra-erythrocytic development of
Plasmodium parasites. Plasmodium falciparum merozoites, the invasive form of the blood …

Africa bears the greatest burden of malaria with more than 200 million clinical cases and
more than 600,000 deaths in 2020 alone. While malaria-associated deaths dropped steadily …

Concerted efforts to fight malaria have caused significant reductions in global malaria cases
and mortality. Sustaining this will be critical to avoid rebound and outbreaks of seasonal …

Human malaria vaccine trials have revealed vaccine efficacy but improvement is still
needed. In this study, we aimed to re-evaluate vaccination with blood-stage naturally …

Reference intervals for common hematological and clinical chemistry parameters constitute
an important basis for health care. Moreover, with increasing priority in drug and vaccine …

The application is directed to in-vitro-reared Plasmodium sporozoites of human host range
wherein sporogony from gametocyte stage to sporozoite stage is external to mosquitoes …

An effective blood-stage vaccine remains elusive but necessary if we are to reduce malaria
morbidity and mortality. The SE36 antigen derived from serine repeat antigen 5 (SERA5) of …

Introducción. La malaria por Plasmodium falciparum es una enfermedad causante de altas
tasas de morbimortalidad a nivel mundial. Diferentes candidatos a vacuna se han evaluado …

The observation that individuals living in malaria endemic regions who are repeatedly
infected with P. falciparum can acquire immunity, first to severe, then to uncomplicated …

Parasite infections affect billions of people and their domesticated animals worldwide, and
remain as a significant cause of morbidity and mortality, but such diseases are still neglected …